Henry B. Lowman
Plus aucun poste en cours
Profil
Henry B.
Lowman worked as a Director in the Antibody Engineering Department at Genentech, Inc. He also worked as a Director in the Protein Sciences department at NGM Biopharmaceuticals, Inc. Prior to that, he was a Vice President of Research at CytomX Therapeutics Holdings LLC from 2010 to 2012.
Lowman received his undergraduate degree from The Johns Hopkins University and his doctorate from Purdue University.
Anciens postes connus de Henry B. Lowman
Sociétés | Poste | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Directeur Technique/Scientifique/R&D | - |
NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Henry B. Lowman
The Johns Hopkins University | Undergraduate Degree |
Purdue University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
NGM BIOPHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
CytomX Therapeutics Holdings LLC
CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Health Technology |